Organovo
75 views | +0 today
Follow
Organovo
Organovo
Your new post is loading...
Your new post is loading...
Scooped by Howard Freedland
Scoop.it!

Organovo: Competition And Profit Potential

Organovo: Competition And Profit Potential | Organovo | Scoop.it
Organovo Holdings, Inc. (NYSEMKT:ONVO) is a development stage company with the aim to produce functional human tissues to be used in drug discovery and development. These tissues will also be employed in therapeutic areas to
Howard Freedland's insight:

ONVO continues to be one of the most interesting biotech companies I know

more...
No comment yet.
Scooped by Howard Freedland
Scoop.it!

How many organs (no matter how minor it is) does a human being have? And what are they?

How many organs (no matter how minor it is) does a human being have? And what are they? | Organovo | Scoop.it
This is really a question with no clear cut answer. It is a human characteristic to want to divide things into discrete categories, but nature itself is not nearly so discriminating. The Terminologica Anatomica lists over 7,500 named parts of the human body.
more...
No comment yet.
Scooped by Howard Freedland
Scoop.it!

Is Organovo Just Hype?

Is Organovo Just Hype? | Organovo | Scoop.it
The technological advancements in the healthcare sector has considerably altered the quality of life for us over the years, and it may get even better if Organovo (ONVO) is successful in doing what it is trying to do - print
more...
No comment yet.
Scooped by Howard Freedland
Scoop.it!

Keith Murphy: The Next Frontier for 3-D Printing: Human Organs - Nextgov.com

Keith Murphy: The Next Frontier for 3-D Printing: Human Organs - Nextgov.com | Organovo | Scoop.it
"Reliance on animal models and cells in a petri dish [for testing] is problematic, because many diseases can't get good animal models or don't behave similarly in petri dishes," says Organovo CEO Keith Murphy.
Howard Freedland's insight:

Another wonderful Organovo article

more...
No comment yet.
Scooped by Howard Freedland
Scoop.it!

Organovo and Methuselah Foundation Announce Funding of Bioprinting Research at Research Institutions

Organovo and Methuselah Foundation Announce Funding of Bioprinting Research at Research Institutions | Organovo | Scoop.it
SAN DIEGO, July 24, 2013 /PRNewswire/ --  Organovo Holdings, Inc.  (NYSE MKT: ONVO), a biotechnology company focused on delivering breakthrough three-dimensional (3D) bioprinting technology, and Methuselah ...
Howard Freedland's insight:

ONVO's technology far surpasses the company's ability to fully exploit it in-house.  Research grants and alliances with 3rd party foundations will permit a more rapid exploitation of this mankind-changing technology

more...
No comment yet.
Scooped by Howard Freedland
Scoop.it!

Organovo Rings Opening Bell On New York Stock Exchange

Organovo Rings Opening Bell On New York Stock Exchange | Organovo | Scoop.it
NEW YORK, July 15, 2013 /PRNewswire/ --  Organovo Holdings, Inc.  (NYSE: ONVO), today rang the opening bell on the New York Stock Exchange (NYSE).  Organovo Holdings, Inc. shares began trading on the NYSE ...
Howard Freedland's insight:

Congratulations to the entire Organovop team.  In addition, CBS Sunday Morning re-ran the piece on Organovo and the future of bio-printing.  Pretty exciting stuff!

more...
No comment yet.
Scooped by Howard Freedland
Scoop.it!

The Growth of Peer-to-Peer Lending: Video

The Growth of Peer-to-Peer Lending: Video | Organovo | Scoop.it
Lending Club Founder and CEO Renaud LaPlanche discusses peer-to-peer lending with Deirdre Bolton on Bloomberg Television's "Money Moves." (Source: Bloomberg)
Howard Freedland's insight:

Renaud Leplance, CEO of Lending Club, took time away from the LendIt Conference to speak with Bloomberg TV.  Great overview of his vision for the direct lending industry.

more...
No comment yet.
Scooped by Howard Freedland
Scoop.it!

Organovo's Breakthrough In Hepatotoxicity Testing

Organovo's Breakthrough In Hepatotoxicity Testing | Organovo | Scoop.it
In late April 2013, Organovo (ONVO.PK) presented data from its all cellular (scaffold free) 3D liver model at the Experimental Biology 2013 conference in Boston.
Howard Freedland's insight:

Another article on Organovo's ability to accelerate drug testing by providing a much more granular test for toxicity.

more...
No comment yet.
Scooped by Howard Freedland
Scoop.it!

2 Medical Device Companies With Revolutionary Platforms

2 Medical Device Companies With Revolutionary Platforms | Organovo | Scoop.it
The medical device sector is comprised of a host of small and large market capitalization companies developing, manufacturing and marketing devices to help improve our quality of life while making big money doing such.
more...
No comment yet.
Scooped by Howard Freedland
Scoop.it!

Organovo: Your New Liver May Be On The Way

Organovo: Your New Liver May Be On The Way | Organovo | Scoop.it
With the current 3D printing market in a state of frenzy, many companies like 3D Systems Corporation (DDD), Stratasys (SSYS), Cimatron (CIMT) and Perceptron (PRCP) sit to reap potentially large benefits.
more...
No comment yet.
Scooped by Howard Freedland
Scoop.it!

Organovo: 3D Bioprinting's Far Reaching Effects Create Long-Term Investment Opportunity

Organovo: 3D Bioprinting's Far Reaching Effects Create Long-Term Investment Opportunity | Organovo | Scoop.it
Bioprinting is new technology that is still evolving, but the process of bioprinting remains the same. Bioprinting uses cells from a moving printer head to place the cells in the correct location.
more...
No comment yet.
Scooped by Howard Freedland
Scoop.it!

The Zen Of LTBH Investing In Volatile Small Caps: Organovo, A Case In Point

The Zen Of LTBH Investing In Volatile Small Caps: Organovo, A Case In Point | Organovo | Scoop.it
Ah, Grasshopper, so you are troubled by the changing value of your share in Organovo Holdings, Inc. (ONVO.PK)? You say in June it was worth $10.90 and three weeks later it was worth $1.93.
more...
No comment yet.
Rescooped by Howard Freedland from SynBioFromLeukipposInstitute
Scoop.it!

Organovo – The Company Behind The First Commercial Bioprinter - 3D Printing Industry

Organovo – The Company Behind The First Commercial Bioprinter - 3D Printing Industry | Organovo | Scoop.it
Organovo is a company that specialises in bioprinting – the laboratory engineering of tissue. Bioengineering is also the focus of several other universities and research instates.

Via Gerd Moe-Behrens
more...
No comment yet.
Scooped by Howard Freedland
Scoop.it!

Organovo Named 2015 Technology Pioneer by World Economic Forum

Organovo Named 2015 Technology Pioneer by World Economic Forum | Organovo | Scoop.it
SAN DIEGO, Aug. 26, 2014 /PRNewswire/ -- Organovo Holdings, Inc. (NYSE MKT: ONVO) ("Organovo"), a three-dimensional biology company focused on delivering pioneering 3D bioprinting technology, announced today that it has been recognized as a 2015 Technology Pioneer by the World Economic Forum (WEF).  Organovo is one of 24 companies honored for the ability to harness creativity to design and create transformative solutions. "We are honored to be named a Technology Pioneer by the World Economic Forum for the innovation and power of Organovo's 3D bioprinting technology," said Keith Murphy, president and CEO of Organovo.  "We see this as a recognition of our team's hard work and dedication to our mission to improve health and medicine on a global scale."   Organovo's leading, commercial 3D bioprinting technology enables the creation of functional human tissues that more accurately reproduce native tissues. The company develops a range of tissue and disease models for medical research, drug testing and therapeutic applications.
Howard Freedland's insight:

Still one of the most amazing technologies I have run across

more...
No comment yet.
Scooped by Howard Freedland
Scoop.it!

The Next Frontier for 3-D Printing: Human Organs

The Next Frontier for 3-D Printing: Human Organs | Organovo | Scoop.it
The technology also is being used to test drug responses in mini-systems.
more...
No comment yet.
Scooped by Howard Freedland
Scoop.it!

Organovo delivers 3D Liver tissue ahead of schedule; shares jump

Organovo delivers 3D Liver tissue ahead of schedule; shares jump | Organovo | Scoop.it
Organovo (ONVO) has delivered the first 3D Liver tissue to a laboratory outside of the company to a "key opinion leader" for experimentation. The target date for the milestone had been April; Organovo expects to have
Howard Freedland's insight:

This is the beginning of a forcastable revenue stream which will pick up spead as ONVO adds additional tissue samples to its lineup.

more...
No comment yet.
Scooped by Howard Freedland
Scoop.it!

Organovo And The Dream Of Printing Body Parts

Organovo And The Dream Of Printing Body Parts | Organovo | Scoop.it
Organovo Holdings (ONVO), a San Diego based development-stage biotech now listed on the New York Stock Exchange, excites investors because it is part of the red hot 3D printing industry.
more...
No comment yet.
Scooped by Howard Freedland
Scoop.it!

Organovo Celebrates Listing on NYSE MKT

On Monday, July 15 San Diego-based Organovo Holdings, a biotechnology company focused on delivering breakthrough three-dimensional (3D) bioprinting technolog...
Howard Freedland's insight:

CONGRATULATIONS to the entire Organovo team.  One more step along the way.

more...
No comment yet.
Scooped by Howard Freedland
Scoop.it!

The Growth of Peer-to-Peer Lending: Video

The Growth of Peer-to-Peer Lending: Video | Organovo | Scoop.it
Lending Club Founder and CEO Renaud LaPlanche discusses peer-to-peer lending with Deirdre Bolton on Bloomberg Television's "Money Moves." (Source: Bloomberg)
Howard Freedland's insight:

Good interview ith Renaud Laplanche, CEO of Lending Club

more...
No comment yet.
Scooped by Howard Freedland
Scoop.it!

Organovo Appoints Tamar D. Howson to Board of Directors

Organovo Appoints Tamar D. Howson to Board of Directors | Organovo | Scoop.it
SAN DIEGO, June 10, 2013 /PRNewswire/ --  Organovo Holdings, Inc.  (OTCQX: ONVO), a biotechnology company focused on delivering breakthrough three-dimensional (3D) bioprinting technology, today announced ...
Howard Freedland's insight:

Organovo continues to improve it's corporate standing, even as it's technology gains deserved visibility.  

more...
No comment yet.
Scooped by Howard Freedland
Scoop.it!

Library - ONVO - Organovo Holdings, Inc. - BoardVote

Library - ONVO - Organovo Holdings, Inc. - BoardVote | Organovo | Scoop.it
Providing investors with the information they need and the opportunity for companies to build a following overnight.
Howard Freedland's insight:

Another accolade for Organovo's technology and innovation

more...
No comment yet.
Scooped by Howard Freedland
Scoop.it!

3D Systems Scrutiny Highlights Promise For 3D Bioprinting

3D Systems Scrutiny Highlights Promise For 3D Bioprinting | Organovo | Scoop.it
The "third industrial revolution" has come under some recent scrutiny, especially with the operations of one of its market leaders, 3D Systems (DDD).
more...
No comment yet.
Scooped by Howard Freedland
Scoop.it!

Organovo's New Partnership Offers Large Upside With Limited Risk

Organovo's New Partnership Offers Large Upside With Limited Risk | Organovo | Scoop.it
Organovo (ONVO.PK) and Knight Cancer Institute at Oregon Health & Science University (OHSU) have formed a collaboration to develop more clinically predictive in vitro three dimensional cancer models.
more...
No comment yet.
Scooped by Howard Freedland
Scoop.it!

With 3D Printing, the Future Is Now

With 3D Printing, the Future Is Now | Organovo | Scoop.it
Although it has been around for nearly 30 years, 3D printing is just now coming into its own.
more...
No comment yet.
Rescooped by Howard Freedland from Amazing Science
Scoop.it!

Organovo partners with Autodesk research to develop 3D bioprinting software

Organovo partners with Autodesk research to develop 3D bioprinting software | Organovo | Scoop.it

Organovo Holdings, Inc., a creator and manufacturer of functional, 3D human tissues for medical research and therapeutic applications, is working together with researchers at Autodesk, Inc., the leader in cloud-based design and engineering software, to create the first 3D design software for bioprinting.

 

The software, which will be used to control Organovo’s NovoGen MMX bioprinter, will represent a major step forward in usability and functionality for designing three-dimensional human tissues, and has the potential to open up bioprinting to a broader group of users, Oraganovo says.

 

“Autodesk is an excellent partner for Organovo in developing new software for 3D bioprinters,” said Keith Murphy, Chairman and Chief Executive Officer at Organovo. “This relationship will lead to advances in bioprinting, including both greater flexibility and throughput internally, and the potential long-term ability for customers to design their own 3D tissues for production by Organovo.”

 

“Bioprinting has the potential to change the world,” said Jeff Kowalski, Senior Vice President and Chief Technology Officer at Autodesk. “It’s a blend of engineering, biology and 3D printing, which makes it a natural for Autodesk. I think working with Organovo to explore and evolve this emerging field will yield some fascinating and radical advances in medical research.”

 

Organovo’s 3D bioprinting technology is used to create living human tissues that are three-dimensional, architecturally correct, and made entirely of living human cells. The resulting structures can function like native human tissues, and represent an opportunity for advancement in medical research, drug discovery and development, and in the future, surgical therapies and transplantation.

 

http://tinyurl.com/bo8as6s


Via Dr. Stefan Gruenwald
more...
No comment yet.